A Study of Efficacy and Safety With the Transdermal Contraceptive System.

NCT00236769 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1751

Enrollment

INDUSTRY

Sponsor class

Conditions

Contraception
Female Contraception

Interventions

DRUG: norelgestromin + ethinyl estradiol

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.